Human papillomaviruses: their clinical significance in the management of cervical carcinoma.
Studies have shown a strong association between certain human papillomaviruses and the development of cervical carcinoma and its precursor lesions. The oncogenic potential of papillomaviruses has been clearly demonstrated in both laboratory animals and cultured cells. Recent advances in our understanding of viral pathogenesis have provided insights into the natural history of papillomavirus infection and subsequent development of neoplasia. A more thorough understanding of the molecular mechanisms responsible for viral oncogenesis will facilitate the development of novel preventive and therapeutic strategies to prevent and treat papillomavirus-associated cervical neoplasias. Strategies under current investigation are focusing on the induction of effective humoral and cell-mediated immunity, the expression of HPV gene products, and cofactors that interact with HPV gene products to affect cell transformation. As a result of these investigative efforts, prophylactic HPV capsid vaccines and other gene therapies may soon become clinically available.
Hines
J F
JF
Dept of Obstetrics and Gynecology, Lombardi Cancer Research Center, Georgetown University Medical Ctr, Washington, DC, USA.
Jenson
A B
AB
Barnes
W A
WA
D002471:Cell Transformation, Neoplastic; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008403:Mass Screening; D027383:Papillomaviridae / Q000276:immunology; D030361:Papillomavirus Infections / Q000150:complications*; D014412:Tumor Virus Infections / Q000150:complications*; D002578:Uterine Cervical Dysplasia / Q000628:therapy / Q000821:virology; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000276:immunology / Q000628:therapy* / Q000821:virology*